{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
tyrosine
to a specific field?
Status:
Investigational
Source:
NCT04019288: Phase 1/Phase 2 Interventional Completed Platinum-Resistant Fallopian Tube Carcinoma
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00471120: Not Applicable Interventional Terminated Uterine Cancer
(2006)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03795142: Early Phase 1 Interventional Completed Healthy Volunteers
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00003431: Phase 1 Interventional Completed Colorectal Cancer
(1998)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT01832051: Phase 2 Interventional Completed Metastatic Breast Cancer
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03371251: Phase 1/Phase 2 Interventional Completed Systemic Lupus Erythematosus
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:davoceticept [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:mecbotamab vedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:anzurstobart [INN]
Source URL:
Class:
PROTEIN
